Michael Nally

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Pittsburgh, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Greg E. Gordon, Attorney-in-Fact for Michael Nally
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael Nally

Form 4 holding Director

PPG INDUSTRIES INC

Security class
Phantom Stock Units
Shares / value
10,339
Estimated value
$865,672
Report date
12 Jun 2026
Price
$103.54
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

PPG INDUSTRIES INC

Security class
Restricted Stock Units
Shares / value
1,684
Estimated value
$215,945
Report date
16 Apr 2026
Price
$116.79
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Generate Biomedicines, Inc.

Security class
Common Stock
Shares / value
1,316,654
Estimated value
Report date
04 Mar 2026
Price
Ownership
By MTN 2024 GST Trust
Form 4 holding Chief Executive Officer, Director

Generate Biomedicines, Inc.

Security class
Common Stock
Shares / value
999,793
Estimated value
Report date
04 Mar 2026
Price
Ownership
By MTN 2024 GRAT
Form 4 holding Chief Executive Officer, Director

Generate Biomedicines, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
844,595
Estimated value
Report date
26 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Generate Biomedicines, Inc.

Security class
Common Stock
Shares / value
572,707
Estimated value
Report date
04 Mar 2026
Price
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

Generate Biomedicines, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
02 Mar 2026
Price
Ownership
By MTN 2024 GST Trust
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Michael Nally

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .